Huifang Chen

发表

DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion

Huabin Li, Hua-Bing Li, Y. Ye, 2022, Nature Communications.

tRNA-m1A modification promotes T cell expansion via efficient MYC protein synthesis

R. Flavell, Xiaoyu Li, C. Yi, 2022, Nature Immunology.

m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-κB–mediated antiapoptotic pathway

Y. Kluger, R. Flavell, Jun Zhao, 2022, Science advances.

m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity

R. Flavell, Zhibin Yu, Zhengting Wang, 2021, Science Advances.

RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1

Shenglin Huang, Leng Han, Y. Ye, 2022, Cancer research.

Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer

Hua-Bing Li, Yanhua Du, Ting Zhang, 2021, Molecular cancer.

Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis.

J. Zhong, Zhengting Wang, Huifang Chen, 2023, Inflammatory bowel diseases.

Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1

Heng-Huan Lee, Jing Liu, Leng Han, 2020, Genome medicine.

Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer

Hua-Bing Li, Yanhua Du, Huifang Chen, 2021, Molecular Cancer.